The use of granulocyte colony stimulating factor (G-CSF) and management of chemotherapy delivery during adjuvant treatment for early-stage breast cancer-Further observations from the IMPACT solid study

导出原文传递

翻译打印收藏纠错

作者： Maenpaa, Johanna ^[1] ; Varthalitis, Ioannis ^[2] ; Erdkamp, Frans ^[3] ; Trojan, Andreas ^[4] ; Krzemieniecki, Krzysztof ^[5] ; Lindman, Henrik ^[6] ; Bendall, Kate ^[7] ; Vogl, Florian D. ^[8] ; Verma, Shailendra ^[9]

作者单位： Amgen Ltd, Uxbridge, Middx, England ^[1] Amgen Inc, Thousand Oaks, CA 91320 USA ^[2] Jagiellonian Univ, Oncol Clin, PL-31007 Krakow, Poland ^[3] Univ Tampere, Tampere Univ Hosp, FIN-33101 Tampere, Finland ^[4] Akad Hosp, Uppsala, Sweden ^[5] Chania Gen Hosp, Khania, Greece ^[6] Brust Zentrum Zurich, Zurich, Switzerland ^[7] Orbis Med Ctr, Sittard, Netherlands ^[8] Ottawa Reg Canc Ctr, Ottawa, ON K1Y 4K7, Canada ^[9]

关键词 Granulocyte colony-stimulating factor Neutropenia Chemotherapy delivery Clinical practice

发布时间 2017-04-06

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

The Breast

2016年25卷

27-33页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

The use of granulocyte colony stimulating factor (G-CSF) and management of chemotherapy delivery during adjuvant treatment for early-stage breast cancer-Further observations from the IMPACT solid study

The Breast

相似文献

The Breast

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

The use of granulocyte colony stimulating factor (G-CSF) and management of chemotherapy delivery during adjuvant treatment for early-stage breast cancer-Further observations from the IMPACT solid study

The Breast

相似文献

The Breast

相关期刊

检索历史清除